| http://www.w3.org/ns/prov#value | - The Global Alliance for TB Drug Development (TB Alliance) and the Novartis Institute for Tropical Diseases (NITD) will collaborate to develop new medicines for TB, including drug-resistant strains and faster TB drug regimens that treat all forms of TB, are easier for patients to complete, and can be used safely in patients with HIV/AIDS. 7 July 2008
|
